Venerdì, 21 Ottobre, 2016

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) stock is worth $16.21

Remigio Civitarese | 19 Ottobre, 2016, 23:03

For the reporting quarter, equity analysts expect the stock to deliver $0.15 in earnings per share (EPS).

FT reports, The 17 analysts offering 12 month price targets for Allscripts Healthcare Solutions Inc have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 14.00. Black Paul offloaded 15,000 shares in the company at a per-share price of $13 and ended up generating $195,000 in proceeds. According to Zacks Investment Research, based on 15 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.03. The company's net profit margin has achieved the current level of 0.2 percent and possesses 43.7 percent gross margin.

One Month Ago Analyst Ratings: The Company has received mean Analyst rating of 2.22 from polled analysts at Reuters One Month Ago. 11 of the brokerages firms have a buy or better rating; the 0 sells versus 0 underperforms. The median estimate represents a -9.74% decrease from the last price of 15.51.

Earnings Estimates for Citigroup Inc. This consensus number is also derived from Zacks.

Wall Street sell-side research analysts covering Allscripts Healthcare Solutions, Inc. EPS ratio determined by looking at last 12 month figures is 0.02.

03/30/2016 - Allscripts Healthcare Solutions, Inc. was upgraded to "overweight" by analysts at Morgan Stanley. The Company provides intuitive clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and services for small to mid-sized practices. Allscripts is headquartered in Chicago, Illinois.

According to Financial Times, The 8 analysts offering 12 month price targets for People's United Financial, Inc. have a median target of 14.00, with a high estimate of 15.50 and a low estimate of 13.00. The median estimate represents a 30.37% increase from the last price of 13.04.

Leerink Partners is following shares of Allscripts Healthcare Solutions, Inc. The report will be for the fiscal Quarter ending Sep 2016. They now have a United States dollars 16 price target on the stock. The company has market value of $2.42B. (NASDAQ:MDRX) tinted loss of -0.23% (-0.03 points) to US$13.01. The company has volume of 1.99 Million shares. The company has a total of 186.27 Million shares outstanding. Top-level EPS estimate is set at $0.19 while low-level EPS estimate among analysts is focused at $0.14. This shows a surprise factor of 0 percent.

The company has YTD performance of -15.41 percent. The current share price indicate that stock is -28.94% away from its one year high and is moving 42.00% ahead of its one year low.

Allscripts Healthcare Solutions, Inc.'s (MDRX) has traded at distance of -0.32% from its 50-day simple moving average and moved at distance of -1.72% from its 200-day simple moving average while exchanged at distance of -0.36% from its 20-day simple moving average. Weekly volatility of MDRX is 2.23% and monthly volatility is 1.93%.

The Company now has ROA (Return on Assets) of 0.1 percent, Return on Equity (ROE) of 0.2 Percent and Return on Investment (ROI) of 1.4% with Gross margin of 43.7 percent and Operating & Profit margin of 4.4% and 0.2% respectively.

Altre Notizie